Mather Group LLC. purchased a new stake in shares of Houlihan Lokey, Inc. (NYSE:HLI – Free Report) during the first quarter, Holdings Channel.com reports. The firm purchased 613 shares of the financial services provider’s stock, valued at approximately $74,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Eagle Asset Management Inc. grew its position in Houlihan Lokey by 11.7% during the fourth quarter. Eagle Asset Management Inc. now owns 118,460 shares of the financial services provider’s stock valued at $14,205,000 after acquiring an additional 12,419 shares during the last quarter. Yousif Capital Management LLC bought a new position in shares of Houlihan Lokey in the fourth quarter worth approximately $2,960,000. Raymond James & Associates grew its holdings in shares of Houlihan Lokey by 14.6% in the fourth quarter. Raymond James & Associates now owns 137,643 shares of the financial services provider’s stock worth $16,505,000 after purchasing an additional 17,544 shares during the last quarter. Victory Capital Management Inc. grew its holdings in shares of Houlihan Lokey by 32.4% in the fourth quarter. Victory Capital Management Inc. now owns 59,208 shares of the financial services provider’s stock worth $7,100,000 after purchasing an additional 14,475 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado grew its holdings in shares of Houlihan Lokey by 36.8% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 165,791 shares of the financial services provider’s stock worth $19,880,000 after purchasing an additional 44,558 shares during the last quarter. 78.07% of the stock is currently owned by institutional investors.
Houlihan Lokey Stock Down 2.3 %
Shares of HLI stock opened at $129.79 on Friday. The stock has a fifty day moving average of $131.29 and a 200 day moving average of $126.09. Houlihan Lokey, Inc. has a 52 week low of $92.51 and a 52 week high of $137.92. The firm has a market capitalization of $8.90 billion, a price-to-earnings ratio of 31.58 and a beta of 0.65.
Houlihan Lokey Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Saturday, June 15th. Investors of record on Monday, June 3rd were paid a $0.57 dividend. This is a positive change from Houlihan Lokey’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend was Monday, June 3rd. This represents a $2.28 dividend on an annualized basis and a yield of 1.76%. Houlihan Lokey’s dividend payout ratio (DPR) is presently 55.47%.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on HLI shares. UBS Group cut their target price on shares of Houlihan Lokey from $157.00 to $145.00 and set a “buy” rating on the stock in a report on Tuesday, May 14th. JMP Securities restated a “market perform” rating on shares of Houlihan Lokey in a report on Tuesday, April 9th.
Read Our Latest Report on Houlihan Lokey
Insider Buying and Selling
In other Houlihan Lokey news, insider David A. Preiser sold 20,000 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $133.21, for a total transaction of $2,664,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 25.97% of the stock is currently owned by insiders.
Houlihan Lokey Company Profile
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Featured Articles
- Five stocks we like better than Houlihan Lokey
- 5 discounted opportunities for dividend growth investors
- McDonald’s Stock: Balancing Value and Innovation
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 6/17 – 6/21
- How to Choose Top Rated Stocks
- Sarepta Therapeutics Stock Soars on FDA Approval
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI – Free Report).
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.